Search - tctmd.com

Displaying 381 - 400 of 477

Sort: Relevancy | Date

Presentation TCT 2013

TCT-2. Comparative Effectiveness of Prasugrel vs. Clopidogrel Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: 30-Day Outcomes from th...

Presenter: Tracy Wang

October 29, 2013

Presentation TCT 2013

TCT-1. Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DES

Presenter: Michael Rinaldi

October 29, 2013

News Conference News TCT 2013

Intraprocedural ST Predicts Adverse Short-Term Events

October 29, 2013

Presentation TCT 2013

Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation

Presenter: Dmitriy Feldman

October 28, 2013

Presentation TCT 2013

Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI

Presenter: Sripal Bangalore

October 27, 2013

Presentation TCT 2013

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.

Presenter: Salvatore Cassese, Robert Byrne, Tomohisa Tada, Lamin King, Adnan Kastrati

January 31, 2013

Presentation TCT 2013

Switching from Clopidogrel to Prasugrel in Patients Undergoing Coronary Stent Implantation

Presenter: Guido Parodi, Benedetta Bellandi, Vincenzo Comito, Renato Valenti, Nazario Carrabba, Rossella Marcucci, Angela Migliorini, Erica Ramazzotti, Rosanna Abbate, David Antoniucci

January 31, 2013

Presentation TCT 2013

Point-of-Care Genetic Testing of Eleven CYP2C19 Single Nucleotide Polymorphisms Identifies Extensive and Reduced Metabolizers of Clopidogrel With High Accuracy in Patients With...

Presenter: David Erlinge, Stefan James, Suman Duvvuru, Joseph Jakubowski, Henrik Wanger, Christoph Varenhorst, Udaya Tantry, Patricia Brown, David Small, Brian Moser, Scott Sundseth, Joseph Walker, Kenneth Winters, Paul Gurbel

January 31, 2013

Presentation TCT 2013

Platelet Function Testing Predicts Bleeding In Patients Exposed To Clopidogrel Undergoing Coronary Artery Bypass Grafting

Presenter: Grant Reed, Elaine Hoffman, Amit Kumar, Andrew Maree, Dalton McLean, Jacki Buros, Sary Aranki, Prem Shekar, Arvind Agnihotri, Laura Williams, Kenneth Rosenfeld, Christopher Cannon

January 31, 2013

Presentation TCT 2013

Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability But Is Associated with Clinical Outcome After Percutaneous Coronary Intervention

Presenter: Jin Joo Park, Kyung Woo Park, Jeehoon Kang, Ki-Hyun Jeon, Si-Hyuck Kang, Jung-Kyu Han, Sang Eun Lee, Han-Mo Yang, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim

January 31, 2013

Presentation TCT 2013

P2Y12 Reactivity units (PRU) to Predict Hyporesponsiveness to Clopidogrel in Patients with Chest Pain with Prior History of Coronary Artery Stenting in Emergency Department

Presenter: Rakesh Sharma, Stephen Erickson, Rohit Sharma, Hanumanth Reddy, Donald Voelker, Harvinder Dod, Vibhuti Singh, james Marsh

January 31, 2013

Presentation TCT 2013

Novel oral anticoagulants in patients with acute coronary syndromes: meta-analysis of randomized controlled trials

Presenter: Andr?s Kom?csi, Andr?s Vorobcsuk, D?niel Kehl, Daniel Aradi

January 31, 2013

Presentation TCT 2013

Nicorandil Prevents Microvascular Dysfunction Resulting from Percutaneous Coronary Intervention in Patients with Stable Angina Pectoris

Presenter: Atsushi Hirohata, Eiki Hirose, Yuhei Kobayashi, Minako Ohara, Tohru Ohe, Fumihiko Sano, Hiroya Takafuji, Hiroyuki Takinami, Keizo Yamamoto, Ryo Yoshioka

January 31, 2013

Presentation TCT 2013

Meta-analysis Comparing Bleeding Rates After Low Versus High Dose Clopidogrel In Patients Undergoing Percutaneous Coronary Intervention And Receiving A Glycoprotein IIb/IIIa...

Presenter: Christopher Huff, Shikhar Agarwal, James Lai, Clay Cauthen, A. Michael Lincoff, Leslie Cho

January 31, 2013

Presentation TCT 2013

Markedly Reduced Platelet Inhibition with Clopidogrel Given To Patients Undergoing Therapeutic Hypothermia Post Cardiac Arrest

Presenter: Rohit Moudgil, Haytham Al-Turbak, Michel Le May, George Wells, Derek So, Alexander Dick, Michael Froeschl, Christopher Glover, Jean-Francois Marquis, Marino Labinaz

January 31, 2013

Presentation TCT 2013

Individual and Regional Variations in Dual Antiplatelet Therapy Dose and Duration in a Large, Randomized International Trial Comparing Two Drug-eluting Stents: Results From...

Presenter: Laura Mauri, Gabriel Steg, Alexis Matteau, Edoardo Camenzind, Eric Boersma, Pascal Vranckx, Patrick Serruys, William O'Neill, Robert Yeh, William Wijns

January 31, 2013

Presentation TCT 2013

Impact of bivalirudin on peri-procedural events in patients undergoing rotational atherectomy: a subanalysis of the randomized ROTAXUS trial

Presenter: Mohamed Abdel-Wahab, Ahmed Khattab, Heinz Joachim B?ttner, Ralph Toelg, Volker Geist, Thomas Meinertz, Franz-Josef Neumann, Gert Richardt

January 31, 2013

Presentation TCT 2013

Impact of Anti-anginal Therapy and Rate Pressure Product Control on the Need for Repeat Revascularization Post-PCI

Presenter: Subhash Banerjee, Rick Weideman, Bertis Little, Mark Weideman, Jennifer Gunter, Kevin Kelly, Emmanouil Brilakis

January 31, 2013

Presentation TCT 2013

Heparin Versus Bivalirudin– In-hospital And 30 Day MACE In Patients Having DES Implantation

Presenter: Evan Shlofmitz, Richard Shlofmitz, Simcha Pollack, Elizabeth Cormier, Elizabeth Haag, Nathaniel Reichek

January 31, 2013

Presentation TCT 2013

Effect of Ticagrelor on the Outcomes of Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From The PLATelet inhibition and patient Outcomes (PLATO) trial

Presenter: Emmanouil Brilakis, Claes Held, Bernhard Meier, Frank Cools, Marc Claeys, Jan Cornel, Philip Aylward, Basil Lewis, Douglas Weaver, Gunnar Brandrup- Wognsen, Susanna Stevens, Lars Wallentin, Stefan James

January 31, 2013

Advertisement

TCT-2. Comparative Effectiveness of Prasugrel vs. Clopidogrel Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: 30-Day Outcomes from th...

TCT-1. Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DES

Intraprocedural ST Predicts Adverse Short-Term Events

Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation

Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.

Switching from Clopidogrel to Prasugrel in Patients Undergoing Coronary Stent Implantation

Point-of-Care Genetic Testing of Eleven CYP2C19 Single Nucleotide Polymorphisms Identifies Extensive and Reduced Metabolizers of Clopidogrel With High Accuracy in Patients With...

Platelet Function Testing Predicts Bleeding In Patients Exposed To Clopidogrel Undergoing Coronary Artery Bypass Grafting

Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability But Is Associated with Clinical Outcome After Percutaneous Coronary Intervention

P2Y12 Reactivity units (PRU) to Predict Hyporesponsiveness to Clopidogrel in Patients with Chest Pain with Prior History of Coronary Artery Stenting in Emergency Department

Novel oral anticoagulants in patients with acute coronary syndromes: meta-analysis of randomized controlled trials

Nicorandil Prevents Microvascular Dysfunction Resulting from Percutaneous Coronary Intervention in Patients with Stable Angina Pectoris

Meta-analysis Comparing Bleeding Rates After Low Versus High Dose Clopidogrel In Patients Undergoing Percutaneous Coronary Intervention And Receiving A Glycoprotein IIb/IIIa...

Markedly Reduced Platelet Inhibition with Clopidogrel Given To Patients Undergoing Therapeutic Hypothermia Post Cardiac Arrest

Individual and Regional Variations in Dual Antiplatelet Therapy Dose and Duration in a Large, Randomized International Trial Comparing Two Drug-eluting Stents: Results From...

Impact of bivalirudin on peri-procedural events in patients undergoing rotational atherectomy: a subanalysis of the randomized ROTAXUS trial

Impact of Anti-anginal Therapy and Rate Pressure Product Control on the Need for Repeat Revascularization Post-PCI

Heparin Versus Bivalirudin– In-hospital And 30 Day MACE In Patients Having DES Implantation

Effect of Ticagrelor on the Outcomes of Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From The PLATelet inhibition and patient Outcomes (PLATO) trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content